Clinical Trial Update: Safety Study of Nebulized RNS60 to Treat Asthma. [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 safety study evaluating inhaled RNS60 for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Asthma | Phase 1 | Status: COMPLETED